A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...
T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...
For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Lung cancer tumor cells in mice communicate with the brain, sending signals to deactivate the body’s immune response, a study ...